China is the bigger Bone & Joint Health Supplements market: $965 Mn against $218 Mn in 2023, about 4.4 times as large.
India grows faster: 9.4% a year, against 7.9%. The gap still grows from $746 Mn to $1.5 Bn by 2033.
Clinical research: 1 active trials in China, 0 in India.
| Measure |  China |  India |
|---|---|---|
| Market size, 2023 | $965 Mn | $218 Mn |
| Market size, 2033 projected | $2.1 Bn | $536 Mn |
| Growth a year (CAGR) | 7.9% | 9.4% |
| Money added, 2023–2033 | $1.1 Bn | $318 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.69 | $0.15 |
| Active clinical trials | 1 | 0 |
| Full report | China report | India report |
Year by year, 2023 to 2033
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Bone & Joint Health Supplements, China or India?
China is the bigger Bone & Joint Health Supplements market: $965 Mn against $218 Mn in 2023, about 4.4 times as large.
Which grows faster in Bone & Joint Health Supplements, China or India?
India grows faster: 9.4% a year, against 7.9%. The gap still grows from $746 Mn to $1.5 Bn by 2033.
More Bone & Joint Health Supplements comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.